Drugs for HER-2-positive Breast Cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Sibilia, Maria (Editor ), Zielinski, Christoph C. (Editor ), Bartsch, Rupert (Editor ), Grunt, Thomas W. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Basel : Springer Basel : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Colección:Milestones in Drug Therapy,
Temas:
Pharmacology.
Oncology.
Cancer.
Immunospecificity.
Immunology.
Internal medicine.
Cancer Biology.
Adaptive Immunity.
Internal Medicine.
Acceso en línea:Texto Completo

Internet

Texto Completo

Items no disponibles

Detalle de Existencias desde

Ejemplares similares